Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mechanism of "tumor cell lysis via missing-self recognition by Natural Killer cells" describes how NK cells identify and destroy cells—including tumor and virally infected cells—that have lost expression of self MHC class I molecules. NK cells are regulated by a balance of activating and inhibitory signals. Inhibitory receptors such as KIR (in humans) and Ly49 (in mice) recognize self MHC I and prevent inappropriate destruction of normal cells. When a cell loses MHC I expression—often as an immune evasion strategy by tumors—it is no longer protected by these inhibitory signals, leading to its recognition and lysis by NK cells. This process is essential for innate tumor surveillance and immune defense, but is a pathway rather than a single molecular target.
Blockade of NK cell inhibitory receptors to enhance killing of tumor cells lacking MHC class I proteins; Cytokine-induced activation of NK cell cytotoxicity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor cell lysis via missing-self recognition by Natural Killer cells.